Universal Health Services, Inc. (0LJL.L)
USD 181.27
(-0.29%)
USD 181.27
(-0.29%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.17 Billion USD | 17.12% |
| 2022 | 1 Billion USD | -26.38% |
| 2021 | 1.36 Billion USD | 0.35% |
| 2020 | 1.35 Billion USD | 11.72% |
| 2019 | 1.21 Billion USD | 3.46% |
| 2018 | 1.17 Billion USD | -8.2% |
| 2017 | 1.28 Billion USD | -0.1% |
| 2016 | 1.28 Billion USD | 1.75% |
| 2015 | 1.25 Billion USD | 18.44% |
| 2014 | 1.06 Billion USD | 4.71% |
| 2013 | 1.01 Billion USD | 7.73% |
| 2012 | 942.58 Million USD | 5.07% |
| 2011 | 897.12 Million USD | 77.4% |
| 2010 | 505.69 Million USD | -2.85% |
| 2009 | 520.53 Million USD | 26.89% |
| 2008 | 410.21 Million USD | 10.79% |
| 2007 | 370.27 Million USD | 14.54% |
| 2006 | 323.26 Million USD | 2.94% |
| 2005 | 314.04 Million USD | -6.19% |
| 2004 | 334.76 Million USD | -9.39% |
| 2003 | 369.46 Million USD | 12.12% |
| 2002 | 329.51 Million USD | 26.52% |
| 2001 | 260.45 Million USD | 31.89% |
| 2000 | 197.47 Million USD | 22.43% |
| 1999 | 161.3 Million USD | 1.26% |
| 1998 | 159.3 Million USD | 27.13% |
| 1997 | 125.3 Million USD | 18.99% |
| 1996 | 105.3 Million USD | 38.92% |
| 1995 | 75.8 Million USD | 42.48% |
| 1994 | 53.2 Million USD | 21.74% |
| 1993 | 43.7 Million USD | -16.44% |
| 1992 | 52.3 Million USD | 37.63% |
| 1991 | 38 Million USD | -6.4% |
| 1990 | 40.6 Million USD | 4.1% |
| 1989 | 39 Million USD | -9.3% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 436.39 Million USD | 12.25% |
| 2024 Q3 | 384.16 Million USD | -11.97% |
| 2024 Q1 | 388.76 Million USD | 17.38% |
| 2023 Q3 | 283.39 Million USD | 1.17% |
| 2023 Q1 | 278.7 Million USD | 6.62% |
| 2023 Q2 | 280.12 Million USD | 0.51% |
| 2023 FY | 1.17 Billion USD | 17.12% |
| 2023 Q4 | 331.19 Million USD | 16.87% |
| 2022 Q2 | 233.43 Million USD | 0.25% |
| 2022 Q4 | 261.38 Million USD | -5.25% |
| 2022 FY | 1 Billion USD | -26.38% |
| 2022 Q1 | 232.85 Million USD | -25.76% |
| 2022 Q3 | 275.88 Million USD | 18.18% |
| 2021 Q2 | 438.96 Million USD | 48.47% |
| 2021 Q1 | 295.66 Million USD | -28.58% |
| 2021 Q3 | 314.8 Million USD | -28.28% |
| 2021 FY | 1.36 Billion USD | 0.35% |
| 2021 Q4 | 313.64 Million USD | -0.37% |
| 2020 Q1 | 236.69 Million USD | -30.58% |
| 2020 Q4 | 413.95 Million USD | 18.39% |
| 2020 Q3 | 349.67 Million USD | -2.34% |
| 2020 Q2 | 358.03 Million USD | 51.26% |
| 2020 FY | 1.35 Billion USD | 11.72% |
| 2019 Q2 | 345.56 Million USD | 1.51% |
| 2019 Q1 | 340.43 Million USD | 31.03% |
| 2019 FY | 1.21 Billion USD | 3.46% |
| 2019 Q3 | 188.92 Million USD | -45.33% |
| 2019 Q4 | 340.97 Million USD | 80.48% |
| 2018 Q4 | 259.82 Million USD | 1.03% |
| 2018 FY | 1.17 Billion USD | -8.2% |
| 2018 Q2 | 324.46 Million USD | -2.8% |
| 2018 Q1 | 333.81 Million USD | -1.46% |
| 2018 Q3 | 257.16 Million USD | -20.74% |
| 2017 FY | 1.28 Billion USD | -0.1% |
| 2017 Q3 | 257.31 Million USD | -22.07% |
| 2017 Q4 | 338.74 Million USD | 31.65% |
| 2017 Q2 | 330.19 Million USD | -6.71% |
| 2017 Q1 | 353.93 Million USD | 12.64% |
| 2016 Q2 | 333.28 Million USD | -6.46% |
| 2016 Q4 | 314.23 Million USD | 13.21% |
| 2016 FY | 1.28 Billion USD | 1.75% |
| 2016 Q1 | 356.32 Million USD | 10.73% |
| 2016 Q3 | 277.56 Million USD | -16.72% |
| 2015 Q2 | 335.39 Million USD | 2.55% |
| 2015 FY | 1.25 Billion USD | 18.44% |
| 2015 Q3 | 275.15 Million USD | -17.96% |
| 2015 Q4 | 321.79 Million USD | 16.95% |
| 2015 Q1 | 327.05 Million USD | 1.48% |
| 2014 Q3 | 176.61 Million USD | -39.81% |
| 2014 Q2 | 293.43 Million USD | 8.29% |
| 2014 Q1 | 270.97 Million USD | 11.7% |
| 2014 FY | 1.06 Billion USD | 4.71% |
| 2014 Q4 | 322.28 Million USD | 82.48% |
| 2013 Q2 | 304.05 Million USD | 24.65% |
| 2013 Q1 | 243.92 Million USD | -11.14% |
| 2013 FY | 1.01 Billion USD | 7.73% |
| 2013 Q4 | 242.6 Million USD | 7.88% |
| 2013 Q3 | 224.88 Million USD | -26.04% |
| 2012 Q3 | 168.71 Million USD | -26.75% |
| 2012 Q1 | 269.02 Million USD | 28.75% |
| 2012 Q4 | 274.5 Million USD | 62.71% |
| 2012 FY | 942.58 Million USD | 5.07% |
| 2012 Q2 | 230.33 Million USD | -14.38% |
| 2011 Q2 | 232.23 Million USD | -10.82% |
| 2011 Q1 | 260.41 Million USD | 99.22% |
| 2011 Q3 | 195.52 Million USD | -15.81% |
| 2011 Q4 | 208.95 Million USD | 6.86% |
| 2011 FY | 897.12 Million USD | 77.4% |
| 2010 Q3 | 104.68 Million USD | -19.32% |
| 2010 FY | 505.69 Million USD | -2.85% |
| 2010 Q4 | 130.71 Million USD | 24.87% |
| 2010 Q1 | 140.54 Million USD | 18.24% |
| 2010 Q2 | 129.74 Million USD | -7.68% |
| 2009 Q2 | 163.04 Million USD | 19.23% |
| 2009 FY | 520.53 Million USD | 26.89% |
| 2009 Q4 | 118.86 Million USD | 16.67% |
| 2009 Q3 | 101.87 Million USD | -37.52% |
| 2009 Q1 | 136.75 Million USD | 54.99% |
| 2008 Q2 | 113.53 Million USD | -10.63% |
| 2008 Q1 | 127.03 Million USD | 43.39% |
| 2008 FY | 410.21 Million USD | 10.79% |
| 2008 Q3 | 82.49 Million USD | -27.34% |
| 2008 Q4 | 88.23 Million USD | 6.96% |
| 2007 FY | 370.27 Million USD | 14.54% |
| 2007 Q4 | 88.59 Million USD | 33.21% |
| 2007 Q1 | 107.16 Million USD | 49.18% |
| 2007 Q2 | 108 Million USD | 0.79% |
| 2007 Q3 | 66.5 Million USD | -38.43% |
| 2006 FY | 323.26 Million USD | 2.94% |
| 2006 Q3 | 70.49 Million USD | -26.39% |
| 2006 Q1 | 85.17 Million USD | 35.22% |
| 2006 Q2 | 95.76 Million USD | 12.43% |
| 2006 Q4 | 71.83 Million USD | 1.91% |
| 2005 FY | 314.04 Million USD | -6.19% |
| 2005 Q4 | 62.98 Million USD | -13.26% |
| 2005 Q3 | 72.61 Million USD | -1.08% |
| 2005 Q2 | 73.4 Million USD | -33.89% |
| 2005 Q1 | 111.03 Million USD | 45.74% |
| 2004 FY | 334.76 Million USD | -9.39% |
| 2004 Q2 | 91.96 Million USD | 3.82% |
| 2004 Q3 | 77.7 Million USD | -15.5% |
| 2004 Q4 | 76.19 Million USD | -1.95% |
| 2004 Q1 | 88.57 Million USD | 4.07% |
| 2003 Q2 | 99.25 Million USD | -2.31% |
| 2003 Q3 | 86.49 Million USD | -12.86% |
| 2003 FY | 369.46 Million USD | 12.12% |
| 2003 Q4 | 85.11 Million USD | -1.59% |
| 2003 Q1 | 101.6 Million USD | 26.16% |
| 2002 Q4 | 80.53 Million USD | 1.88% |
| 2002 FY | 329.51 Million USD | 26.52% |
| 2002 Q1 | 86.76 Million USD | 36.68% |
| 2002 Q2 | 83.16 Million USD | -4.16% |
| 2002 Q3 | 79.04 Million USD | -4.95% |
| 2001 Q3 | 61.17 Million USD | -5.98% |
| 2001 Q2 | 65.06 Million USD | -8.01% |
| 2001 Q4 | 63.48 Million USD | 3.77% |
| 2001 FY | 260.45 Million USD | 31.89% |
| 2001 Q1 | 70.73 Million USD | 40.24% |
| 2000 Q4 | 50.43 Million USD | 11.24% |
| 2000 Q1 | 54.71 Million USD | 59.07% |
| 2000 Q2 | 46.98 Million USD | -14.13% |
| 2000 Q3 | 45.33 Million USD | -3.51% |
| 2000 FY | 197.47 Million USD | 22.43% |
| 1999 Q2 | 46.3 Million USD | -20.45% |
| 1999 Q1 | 58.2 Million USD | 45.14% |
| 1999 FY | 161.3 Million USD | 1.26% |
| 1999 Q4 | 34.4 Million USD | 52.21% |
| 1999 Q3 | 22.6 Million USD | -51.19% |
| 1998 Q1 | 47.9 Million USD | 70.46% |
| 1998 FY | 159.3 Million USD | 27.13% |
| 1998 Q3 | 28.9 Million USD | -31.68% |
| 1998 Q4 | 40.1 Million USD | 38.75% |
| 1998 Q2 | 42.3 Million USD | -11.69% |
| 1997 Q4 | 28.1 Million USD | 6.44% |
| 1997 FY | 125.3 Million USD | 18.99% |
| 1997 Q1 | 39 Million USD | 36.36% |
| 1997 Q2 | 31.8 Million USD | -18.46% |
| 1997 Q3 | 26.4 Million USD | -16.98% |
| 1996 Q2 | 25.2 Million USD | -12.5% |
| 1996 Q1 | 28.8 Million USD | 18.03% |
| 1996 FY | 105.3 Million USD | 38.92% |
| 1996 Q4 | 28.6 Million USD | 25.44% |
| 1996 Q3 | 22.8 Million USD | -9.52% |
| 1995 Q2 | 15.9 Million USD | -23.92% |
| 1995 FY | 75.8 Million USD | 42.48% |
| 1995 Q4 | 24.4 Million USD | 67.12% |
| 1995 Q3 | 14.6 Million USD | -8.18% |
| 1995 Q1 | 20.9 Million USD | 137.5% |
| 1994 Q1 | 18.6 Million USD | 186.15% |
| 1994 Q2 | 14.7 Million USD | -20.97% |
| 1994 Q3 | 11.1 Million USD | -24.49% |
| 1994 Q4 | 8.8 Million USD | -20.72% |
| 1994 FY | 53.2 Million USD | 21.74% |
| 1993 Q2 | 11.9 Million USD | -24.68% |
| 1993 Q3 | 9.5 Million USD | -20.17% |
| 1993 Q4 | 6.5 Million USD | -31.58% |
| 1993 FY | 43.7 Million USD | -16.44% |
| 1993 Q1 | 15.8 Million USD | 102.56% |
| 1992 FY | 52.3 Million USD | 37.63% |
| 1992 Q4 | 7.8 Million USD | -6.02% |
| 1992 Q3 | 8.3 Million USD | -36.15% |
| 1992 Q2 | 13 Million USD | -43.23% |
| 1992 Q1 | 22.9 Million USD | 1172.22% |
| 1991 Q3 | 7 Million USD | -43.55% |
| 1991 Q4 | 1.8 Million USD | -74.29% |
| 1991 Q2 | 12.4 Million USD | -26.63% |
| 1991 FY | 38 Million USD | -6.4% |
| 1991 Q1 | 16.9 Million USD | 138.03% |
| 1990 FY | 40.6 Million USD | 4.1% |
| 1990 Q2 | 11.2 Million USD | -93.27% |
| 1990 Q4 | 7.1 Million USD | -8.97% |
| 1990 Q1 | 166.5 Million USD | 141.45% |
| 1990 Q3 | 7.8 Million USD | -30.36% |
| 1989 FY | 39 Million USD | -9.3% |
| 1989 Q3 | 140.2 Million USD | -4.63% |
| 1989 Q1 | 153.5 Million USD | 141.04% |
| 1989 Q2 | 147 Million USD | -4.23% |
| 1989 Q4 | -401.7 Million USD | -386.52% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 991.974% |
| Accuray Incorporated | 504 Thousand USD | -233110.516% |
| Align Technology, Inc. | 643.33 Million USD | -82.7% |
| Elevance Health Inc. | 133.96 Billion USD | 99.123% |
| AxoGen, Inc. | -21.46 Million USD | 5576.568% |
| Boston Scientific Corporation | 2.34 Billion USD | 49.834% |
| CVS Health Corporation | 13.74 Billion USD | 91.447% |
| Cardinal Health, Inc. | 1.24 Billion USD | 5.44% |
| Centene Corporation | 2.93 Billion USD | 59.885% |
| DaVita Inc. | 1.6 Billion USD | 26.666% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 87.791% |
| Hologic, Inc. | 970.2 Million USD | -21.148% |
| Humana Inc. | 4.01 Billion USD | 70.711% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -7.133% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -61.987% |
| Masimo Corporation | 136.5 Million USD | -761.085% |
| McKesson Corporation | 3.9 Billion USD | 69.931% |
| Patterson Companies, Inc. | 252.92 Million USD | -364.717% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 6.864% |
| ResMed Inc. | 1.31 Billion USD | 10.949% |
| Henry Schein, Inc. | 615 Million USD | -91.119% |
| Teladoc Health, Inc. | -248.55 Million USD | 572.889% |
| Veeva Systems Inc. | 429.33 Million USD | -173.768% |
| Baxter International Inc. | 390 Million USD | -201.38% |
| Becton, Dickinson and Company | 2.11 Billion USD | 44.321% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 33.474% |
| Danaher Corporation | 5.38 Billion USD | 78.157% |
| Stryker Corporation | 3.88 Billion USD | 69.769% |
| Medtronic plc | 5.14 Billion USD | 77.15% |